At the F.D.A.’s urging, Pfizer-BioNTech and Moderna are expanding their studies of children 5 to 11.

By BY SHERYL GAY STOLBERG, SHARON LAFRANIERE AND NOAH WEILAND from NYT U.S. https://ift.tt/3eYD9Ci
via IFTTT At the F.D.A.’s urging, Pfizer-BioNTech and Moderna are expanding their studies of children 5 to 11. It was unclear whether expanding the studies will have any impact on the timing of when vaccines could be authorized for children on an emergency basis. BY SHERYL GAY STOLBERG, SHARON LAFRANIERE AND NOAH WEILAND https://ift.tt/3eYD9Ci https://ift.tt/3ibeYml New York Times U.S. Children and Childhood, Clinical Trials, Coronavirus (2019-nCoV), Vaccination and Immunization July 26, 2021 at 11:30PM